ANKRD17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.625000E-01
Normal-vs-Stage2
6.254400E-01
Normal-vs-Stage3
8.083900E-02
Normal-vs-Stage4
5.694400E-01
Stage1-vs-Stage2
2.773200E-01
Stage1-vs-Stage3
1.034160E-02
Stage1-vs-Stage4
5.434000E-01
Stage2-vs-Stage3
1.436030E-01
Stage2-vs-Stage4
8.989500E-02
Stage3-vs-Stage4
1.186820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.662600E-01
Normal-vs-AfricanAmerican
7.652600E-01
Normal-vs-Asian
4.515000E-01
Caucasian-vs-AfricanAmerican
2.361000E-01
Caucasian-vs-Asian
3.800800E-01
AfricanAmerican-vs-Asian
1.940980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.245000E-01
Normal-vs-Female
7.742000E-01
Male-vs-Female
4.943400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.982200E-01
Normal-vs-Age(41-60Yrs)
9.099200E-01
Normal-vs-Age(61-80Yrs)
5.057200E-01
Normal-vs-Age(81-100Yrs)
3.544200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.459200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.773200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.564800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.838500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.229700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.472400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.783400E-01
Normal-vs-Daily Drinker
1.947610E-01
Normal-vs-Weekly Drinker
4.462600E-01
Normal-vs-Occasional Drinker
9.073400E-01
Normal-vs-Social Drinker
8.706600E-01
Non Drinker-vs-Daily Drinker
4.070800E-01
Non Drinker-vs-Weekly Drinker
9.934600E-01
Non Drinker-vs-Occasional Drinker
1.295160E-01
Non Drinker-vs-Social Drinker
1.474560E-01
Daily Drinker-vs-Weekly Drinker
5.127000E-01
Daily Drinker-vs-Occasional Drinker
3.020000E-02
Daily Drinker-vs-Social Drinker
6.290000E-02
Weekly Drinker-vs-Occasional Drinker
2.232200E-01
Weekly Drinker-vs-Social Drinker
1.906240E-01
Occasional Drinker-vs-Social Drinker
6.115200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.546620E-01
Normal-vs-Grade 2
4.138200E-02
Normal-vs-Grade 3
2.252400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.108400E-01
Grade 1-vs-Grade 3
6.020200E-01
Grade 1-vs-Grade 4
1.546620E-01
Grade 2-vs-Grade 3
2.946600E-01
Grade 2-vs-Grade 4
4.138200E-02
Grade 3-vs-Grade 4
2.252400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.715000E-01
Normal-vs-NonDiabetic
6.038800E-01
Diabetic-vs-NonDiabetic
3.298000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.522400E-01
Normal-vs-NoPancreatitis
5.971200E-01
Pancreatitis-vs-NoPancreatitis
6.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.006000E-01
Normal-vs-N1
6.504600E-01
N0-vs-N1
7.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.838200E-01
Normal-vs-TP53-NonMutant
9.575000E-01
TP53-Mutant-vs-TP53-NonMutant
5.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
